The European Medicines Agency has approved a phase 2 clinical trial for the Respiratory Syncytial Virus (RSV) vaccine, developed by Chilean researchers led by…
In a column written by Dr. Luis Pizarro and Pedro Bouchon they explain the urgency for countries like ours to tackle Neglected Diseases and the advantage for…
Over 10% of Chile's health care budget goes on treating chronic pain, which is the equivalent of the country's total yearly research investment, including…
Published in one of the most prestigious medical journals globally, this is the first research that measures more than ten million people vaccinated under…
In the context of the international study "CONCORD-19" in Chile, faculty members of the UC School of Medicine will lead the follow-up process of more than 300…
The world is frantically looking for a vaccine that will prevent infections of the novel coronavirus. Among the more than 100 research teams trying to develop…